FNY Investment Advisers’s Context Therapeutics CNTX Stock Holding History

FNY Investment Advisers’s Portfolio CNTX Stock Details CNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3K	Hold	6,000	–	–	﹤0.01%	711
2026 Q1	$15K	Buy	+6,000	New	+$14K	0.01%	501

Other funds holding CNTX

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

FNY Investment Advisers's CNTX Position: Q2 2026 in Review

FNY Investment Advisers held its Context Therapeutics (CNTX) position steady in Q2 2026 at 6,000 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #711.

FNY Investment Advisers first reported a position in CNTX in Q1 2026 and has held it in 2 quarters since. The position peaked at $15K in Q1 2026. 2 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

FNY Investment Advisers held 6,000 shares of Context Therapeutics worth $3K as of Q2 2026.
FNY Investment Advisers left its Context Therapeutics share count unchanged in Q2 2026.
Context Therapeutics made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #711 holding.
FNY Investment Advisers first reported a position in Context Therapeutics in Q1 2026 and has held it in 2 quarters since.
FNY Investment Advisers's Context Therapeutics position peaked at $15K in Q1 2026.
2 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.